Siga Technologies (SIGA) Net Income towards Common Stockholders Growth (1y) (2011 - 2025)
Powered by 
Analysis
Siga Technologies (SIGA) Net Income towards Common Stockholders Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | -0.05% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 284.27% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -130.19% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -19.23% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -108.13% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -91.06% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 44.59% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 7.59% |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -573.67% |
| Jun 30, 2025 | 1,873.05% |
| Mar 31, 2025 | -103.60% |
| Dec 31, 2024 | -36.67% |
| Sep 30, 2024 | 441.91% |
| Jun 30, 2024 | 162.52% |
| Mar 31, 2024 | 1,219.93% |
| Dec 31, 2023 | 9,000.73% |
| Sep 30, 2023 | -101.19% |
| Jun 30, 2023 | -244.68% |
| Mar 31, 2023 | -154.17% |
| Dec 31, 2022 | -101.11% |
| Sep 30, 2022 | 1,161.25% |
| Jun 30, 2022 | 867.59% |
| Mar 31, 2022 | 79.14% |
| Dec 31, 2021 | 263.98% |
| Sep 30, 2021 | -112.87% |
| Jun 30, 2021 | -101.24% |
| Mar 31, 2021 | 80.55% |
| Dec 31, 2020 | 518.36% |